Highly Sensitive Detection Method for HV69-70del in SARS-CoV-2 Alpha and Omicron Variants Based on CRISPR/Cas13a

As SARS-CoV-2 variants continue to evolve, identifying variants with adaptive diagnostic tool is critical to containing the ongoing COVID-19 pandemic. Herein, we establish a highly sensitive and portable on-site detection method for the HV69-70del which exist in SARS-CoV-2 Alpha and Omicron variants...

Full description

Bibliographic Details
Main Authors: Dong, X. (Author), Han, Y. (Author), Hu, Q. (Author), Li, F. (Author), Li, H. (Author), Niu, M. (Author), Sun, Y. (Author), Xia, X. (Author), Yang, L. (Author), Zhang, Y. (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
RNA
Online Access:View Fulltext in Publisher
LEADER 02810nam a2200493Ia 4500
001 10.3389-fbioe.2022.831332
008 220510s2022 CNT 000 0 und d
020 |a 22964185 (ISSN) 
245 1 0 |a Highly Sensitive Detection Method for HV69-70del in SARS-CoV-2 Alpha and Omicron Variants Based on CRISPR/Cas13a 
260 0 |b Frontiers Media S.A.  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3389/fbioe.2022.831332 
520 3 |a As SARS-CoV-2 variants continue to evolve, identifying variants with adaptive diagnostic tool is critical to containing the ongoing COVID-19 pandemic. Herein, we establish a highly sensitive and portable on-site detection method for the HV69-70del which exist in SARS-CoV-2 Alpha and Omicron variants using a PCR-based CRISPR/Cas13a detection system (PCR-CRISPR). The specific crRNA (CRISPR RNA) targeting the HV69-70del is screened using the fluorescence-based CRISPR assay, and the sensitivity and specificity of this method are evaluated using diluted nucleic acids of SARS-CoV-2 variants and other pathogens. The results show that the PCR-CRISPR detection method can detect 1 copies/μL SARS-CoV-2 HV69-70del mutant RNA and identify 0.1% of mutant RNA in mixed samples, which is more sensitive than the RT-qPCR based commercial SARS-CoV-2 variants detection kits and sanger sequencing. And it has no cross reactivity with ten other pathogens nucleic acids. Additionally, by combined with our previously developed ERASE (Easy-Readout and Sensitive Enhanced) lateral flow strip suitable for CRISPR detection, we provide a novel diagnosis tool to identify SARS-CoV-2 variants in primary and resource-limited medical institutions without professional and expensive fluorescent detector. Copyright © 2022 Niu, Han, Dong, Yang, Li, Zhang, Hu, Xia, Li and Sun. 
650 0 4 |a Biomolecules 
650 0 4 |a CRISPR/cas13a 
650 0 4 |a CRISPR/Cas13a 
650 0 4 |a Detection methods 
650 0 4 |a Detection system 
650 0 4 |a Diagnosis 
650 0 4 |a Diagnostics tools 
650 0 4 |a Diseases 
650 0 4 |a Fluorescence 
650 0 4 |a Highly sensitive detections 
650 0 4 |a Lateral Flow 
650 0 4 |a lateral flow strip 
650 0 4 |a Lateral flow strip 
650 0 4 |a nucleic acid detection 
650 0 4 |a On-site detection 
650 0 4 |a Polymerase chain reaction 
650 0 4 |a RNA 
650 0 4 |a SARS 
650 0 4 |a SARS-CoV-2 
650 0 4 |a Variant 
650 0 4 |a variants 
700 1 |a Dong, X.  |e author 
700 1 |a Han, Y.  |e author 
700 1 |a Hu, Q.  |e author 
700 1 |a Li, F.  |e author 
700 1 |a Li, H.  |e author 
700 1 |a Niu, M.  |e author 
700 1 |a Sun, Y.  |e author 
700 1 |a Xia, X.  |e author 
700 1 |a Yang, L.  |e author 
700 1 |a Zhang, Y.  |e author 
773 |t Frontiers in Bioengineering and Biotechnology